Moderna President Sells $17M in Stock Amid Overvaluation Concerns

R
Rich

Moderna (MRNA) President Stephen Hoge sold approximately $17.01 million worth of company stock on October 14-15, following option exercises. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan .

Key details:

  • Sale Value: $17.01 million
  • Shares Sold: 78,369 shares at weighted average prices between $213.47 and $220.72
  • Option Exercise: Hoge also acquired 152,905 shares via option exercises at $12.21 per share
  • Context: MRNA stock has returned 738% over the past year and is currently trading at $218.01. InvestingPro analysis suggests the stock appears overvalued relative to its Fair Value .
Moderna president Stephen Hoge sells $17m in stock

Moderna president Stephen Hoge sells $17m in stock

INVESTING.COMOct 17, 8:16 AM UTC
0

Related Articles